PCR52 Use of Patient Reported Outcomes in Key Trials Supporting Marketing Authorisation: 5-Year Analysis of Company Evidence Submitted for National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA)
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.2491
https://www.valueinhealthjournal.com/article/S1098-3015(23)05621-8/fulltext
Section Title :
Section Order :
11833
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05621-8&doi=10.1016/j.jval.2023.09.2491